arrow
返回
D

Dawn C. Schwenke

US Department of Veterans Affairs

38H指数
133论文数
7.2K被引数
收录论文 71
发表时间
err分享
err收藏
The US Department of Veterans Affairs Science and Health Initiative to Combat Infectious and Emerging Life-Threatening Diseases (VA SHIELD): A Biorepository Addressing National Health Threats
err2022-12-14
err1
errOAAI
errHarley, John B.; Pyarajan, Saiju; Partan, Elizabeth S.; Epstein, Lauren; Wertheim, Jason A.; Diwan, Abhinav; Woods, Christopher W.; Davey, Victoria; Blair, Sharlene; Clark, Dennis H.; Kaufman, Kenneth M.; Khan, Shagufta; Chepelev, Iouri; Devine, Alexander; Cameron, Perry; McCann, Monica F.; Ammons, Mary Cloud B.; Bolz, Devin D.; Battles, Jane K.; Curtis, Jeffrey L.; Holodniy, Mark; Marconi, Vincent C.; Searles, Charles D.; Beenhouwer, David O.; Brown, Sheldon T.; Moorman, Jonathan P.; Yao, Zhi Q.; Rodriguez-Barradas, Maria C.; Mohapatra, Shyam; De Rodriguez, Osmara Y. Molina; Padiernos, Emerson B.; McIndoo, Eric R.; Price, Emily; Burgoyne, Hailey M.; Robey, Ian; Schwenke, Dawn C.; Shive, Carey L.; Przygodzki, Ronald M.; Ramoni, Rachel B.; Krull, Holly K.; Bonomo, Robert A.
err分享
err收藏
err分享
err收藏
Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial
err2018-08-06
err99
errOAAI
errZhou, Jin J.; Schwenke, Dawn C.; Bahn, Gideon; Reaven, Peter
err分享
err收藏
Glycemic Variation and Cardiovascular Risk during the VADT
err2018-07-01
err0
PREAI
errZhou, Jin; Schwenke, Dawn; Reaven, Peter
err分享
err收藏
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
err2017-02-01
err74
errOAAI
errSaremi, Aramesh; Howell, Scott; Schwenke, Dawn C.; Bahn, Gideon; Beisswenger, Paul J.; Reaven, Peter D.
err分享
err收藏
Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes
err2016-05-01
err47
errOAAI
errKoska, Juraj; Yassine, Hussein; Trenchevska, Olgica; Sinari, Shripad; Schwenke, Dawn C.; Yen, Frances T.; Billheimer, Dean; Nelson, Randall W.; Nedelkov, Dobrin; Reaven, Peter D.
err分享
err收藏
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW
err2016-05-01
err30
errOAAI
errTripathy, Devjit; Schwenke, Dawn C.; Banerji, MaryAnn; Bray, George A.; Buchanan, Thomas A.; Clement, Stephen C.; Henry, Robert R.; Kitabchi, Abbas E.; Mudaliar, Sunder; Ratner, Robert E.; Stentz, Frankie B.; Musi, Nicolas; Reaven, Peter D.; DeFronzo, Ralph A.
err分享
err收藏
Barriers to Adoption of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure: A Mixed-Methods Study
err2016-03-09
err23
errOAAI
errDev, Sandesh; Hoffman, Trisha K.; Kavalieratos, Dio; Heidenreich, Paul; Wu, Wen-Chih; Schwenke, Dawn C.; Tracy, Sarah J.
err分享
err收藏
Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD
err2015-05-13
err33
errOAAI
errBelalcazar, L. Maria; Lang, Wei; Haffner, Steven M.; Schwenke, Dawn C.; Kriska, Andrea; Balasubramanyam, Ashok; Hoogeveen, Ron C.; Pi-Sunyer, F. Xavier; Tracy, Russell P.; Ballantyne, Christie M.
err分享
err收藏
A Novel Insulin Resistance Index to Monitor Changes in Insulin Sensitivity and Glucose Tolerance: the ACT NOW Study
err2015-05-01
err30
errOAAI
errTripathy, Devjit; Cobb, Jeff E.; Gall, Walter; Adam, Klaus-Peter; George, Tabitha; Schwenke, Dawn C.; Banerji, MaryAnn; Bray, George A.; Buchanan, Thomas A.; Clement, Stephen C.; Henry, Robert R.; Kitabchi, Abbas E.; Mudaliar, Sunder; Ratner, Robert E.; Stentz, Frankie B.; Reaven, Peter D.; Musi, Nicolas; Ferrannini, Ele; DeFronzo, Ralph A.
err分享
err收藏
Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
err2015-02-26
err127
errOAAI
errKoska, Juraj; Sands, Michelle; Burciu, Camelia; D'Souza, Karen M.; Raravikar, Kalyani; Liu, James; Truran, Seth; Franco, Daniel A.; Schwartz, Eric A.; Schwenke, Dawn C.; D'Alessio, David; Migrino, Raymond Q.; Reaven, Peter D.
err分享
err收藏